FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Original Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved an extended-release dexmethylphenidate hydrochloride product from Par Health USA, LLC through an Original Application (ANDA), marking a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (dexmethylphenidate hydrochloride extended-release)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE)